TY  - GEN
AU  - Samama,C M
TI  - [Bounderies of the authorization to market and the therapeutic impass]
SN  - 0750-7658
PY  - 2001///0906
KW  - Anticoagulants
KW  - adverse effects
KW  - Chondroitin Sulfates
KW  - Dermatan Sulfate
KW  - Drug Approval
KW  - legislation & jurisprudence
KW  - Drug Combinations
KW  - France
KW  - Heparin
KW  - Heparitin Sulfate
KW  - Hirudin Therapy
KW  - Hirudins
KW  - Humans
KW  - Recombinant Proteins
N1  - Publication Type: Editorial
UR  - https://doi.org/10.1016/s0750-7658(01)00438-5
ER  -